| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8db7fa33e5e8cf9673fcac2a6a8c5b4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate |
2010-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41b2f828700acb68a05b4e685f5797a1 |
| publicationDate |
2012-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2012001290-A |
| titleOfInvention |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE. |
| abstract |
This application describes compositions of receptor inhibitors, including typical antipsychotic agents, for example, haloperidol, and methods of use for the treatment of clinical signs or symptoms of Parkinson's disease. In addition, this application describes compositions and methods for inducing supersensitivity in dopamine D2 receptors and other receptors involved in Parkinson's disease as a means to relieve the clinical signs or symptoms of Parkinson's disease. |
| priorityDate |
2009-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |